An abrupt aversion to sex is a common, albeit lesser-known, complication of taking GLP-1 medications, such as Mounjaro, ...

Lilly's share price rose >500% during the same period ... 68 weeks compared to a reduction of 11.8% with cagrilintide 2.4 mg, 16.1% with semaglutide 2.4 mg and 2.3% with placebo alone.

Like most drugs, Mounjaro can cause side effects. Hair loss was not a reported side effect of Mounjaro, but it was reported with other GLP-1 agonists. Mounjaro can cause side effects, such as ...

Medicare may cover Mounjaro for type 2 diabetes, but it does not currently cover weight loss medications. If a person is eligible for Mounjaro, coverage may depend on their prescription drug plan ...

The usual beginners' dose of Mounjaro is 2.5 milligrams once a week for the first 4 weeks [7]. Some doctors will continue to increase the dosage as much as 2.5 mg every 4 weeks up to a maximum ...

Whether you've been prescribed Mounjaro (tirzepatide) for type 2 diabetes, weight loss, or both, you're likely wondering what to eat (and not to eat) while taking the medication. After all, a ...

Eli Lilly is experiencing explosive growth thanks to its diabetes and obesity treatments. Beyond weight loss, the company is quietly building a fast-growing oncology business. This is an enormous ...

While Novo Nordisk's Ozempic is the most mainstream GLP-1 medication, Eli Lilly (NYSE: LLY) has two blockbuster weight loss drugs of its own: Mounjaro and Zepbound. Mounjaro and Zepbound are by ...